What is Bridgeway Diagnostics?
Bridgeway Diagnostics operates as a physician-owned diagnostic radiology practice, distinguishing itself through a comprehensive suite of screening and imaging services. The company provides critical diagnostic tools, including low-dose CT, X-Ray, Ultrasound, DXA, and digital mammography. As a regional leader, it holds the distinction of being the first outpatient facility to implement advanced radiation dose reduction CT and low-dose 3D breast tomography. By catering to complex patient needs—such as those with metal implants or requirements for non-contrast MRI—the firm maintains a high standard of care across its locations in Auburn, Columbus, and Phenix City. Its market position is defined by a synthesis of clinical expertise and technological innovation, aimed at improving early detection outcomes.
How much funding has Bridgeway Diagnostics raised?
Bridgeway Diagnostics has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Bridgeway Diagnostics
PPP
Public-Private Partnership
What's next for Bridgeway Diagnostics?
Looking ahead, the strategic deployment of this capital will likely focus on scaling operational capacity and further integrating cutting-edge diagnostic hardware. Given the late-stage nature of this funding, Bridgeway Diagnostics is expected to prioritize market consolidation and the optimization of its existing service centers. The firm's focus on high-precision imaging, such as 3D breast tomography, suggests a roadmap centered on clinical excellence and the expansion of its patient base. By maintaining its physician-owned structure, the company is poised to navigate the evolving healthcare landscape, potentially exploring further technological upgrades or geographic expansion to meet the growing demand for specialized outpatient diagnostic services.
See full Bridgeway Diagnostics company page
